fda semaglutide warning september 2025 The has issued a to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and FDA issued 25 warning letters

Exploratory Cardiovascular Risk Modeling of Orforglipron Using the PREVENT Equations Compared with the Pooled Cohort Equations: A Post-Hoc Analysis from a Systematic Review and Meta-analysis, High Blood Pressure & Cardiovascular Prevention, (2026)

Individuals with active gastrointestinal conditionsincluding inflammatory bowel disease (Crohn's disease, ulcerative colitis)should seek medical advice and follow American Gastroenterological Association guidance regarding strain-specific, condition-specific probiotic use

How It Works Step 1: Complete our secure online purchase form

If you have these conditions, semaglutide is generally not recommended

Discover the full range of Melanotan 2 products here

Management of hyperglycemia in type 2 diabetes, 2022